PROKIDNEY CORP (PROK) Stock Earnings & Estimates
USA - NASDAQ:PROK - US74291D1046 - Common Stock
3.06 USD
-0.02 (-0.65%)
3.09 USD
+0.03 (+0.98%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 76K | 434.52K 471.74% | 106.488K -75.49% | 53.676M 50,305.68% | 155.14M 189.03% | 349.25M 125.12% | 585.45M 67.63% | 827.28M 41.31% | 1.095B 32.36% | |||
| EBITDA YoY % growth | -149.97M -182.27% | -147.669M 1.53% | -172.92M -17.10% | -166.086M 3.95% | -182.859M -10.10% | -198.315M -8.45% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -153.01M -177.64% | -151.522M 0.97% | -178.352M -17.71% | -176.81M 0.86% | -196.71M -11.25% | -212.069M -7.81% | -120.078M 43.38% | -44.24M 63.16% | 60.046M 235.73% | 174.4M 190.44% | 307.22M 76.16% | |
| Operating Margin | N/A | N/A | -234,673.68% | -40,690.88% | -184,724.78% | -395.09% | -77.40% | -12.67% | 10.26% | 21.08% | 28.06% | |
| EPS YoY % growth | N/A | -0.57 51.54% | -0.63 -10.53% | -0.52 18.08% | -0.53 -2.21% | -0.45 13.92% | -0.36 21.38% | -0.26 28.57% | -0.04 84.00% | 0.15 475.00% | 0.41 166.67% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.13 3.83% | -0.13 22.00% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | -44.88M 0.52% | -49.307M -6.87% |
| EBIT Q2Q % growth | -47.293M 3.43% | -54.681M -6.03% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.13 18.75% | -0.15 | 0.02 | 11.49% |
| Q1 2025 Q2Q % growth | -0.13 18.75% | -0.16 | 0.03 | 19.08% |
| Q4 2024 Q2Q % growth | -0.17 -88.89% | -0.15 | -0.02 | -12.23% |
| Q3 2024 Q2Q % growth | -0.14 22.22% | -0.15 | 0.01 | 5.99% |
| Q2 2024 Q2Q % growth | -0.16 -14.29% | -0.17 | 0.01 | 8.40% |
| Q1 2024 Q2Q % growth | -0.16 | -0.18 | 0.02 | 12.37% |
| Q4 2023 Q2Q % growth | -0.09 18.18% | -0.17 | 0.08 | 48.25% |
| Q3 2023 Q2Q % growth | -0.18 -38.46% | -0.16 | -0.02 | -11.83% |
| Q2 2023 Q2Q % growth | -0.14 | -0.40 | 0.26 | 65.12% |
| Q1 2023 Q2Q % growth | -0.16 | -0.40 | 0.24 | 59.93% |
| Q4 2022 Q2Q % growth | -0.11 | -0.25 | 0.14 | 56.02% |
| Q3 2022 Q2Q % growth | -0.13 | -0.24 | 0.11 | 45.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.22% | 8.33% | 2.05% | 8.37% |
| Revenue | N/A | N/A | 8.31% | 208.7% |